Sepsis is an alarmingly common cause behind ICU admissions in patients with multiple sclerosis (MS), a retrospective, population-based cohort study indicates. Furthermore, it contributes to a ...
A study, published in the Journal of Hospital Infection, examines the impact of inactive antimicrobial therapy on sepsis patients in the intensive care unit. Researchers conducted a retrospective, ...
Changes in intensive care unit management over time can greatly reduce patients’ risk of sepsis, according to research published in the Journal of the American Medical Association. Researchers in ...
In a new development, researchers have created an AI-driven model capable of predicting mortality risk in sepsis patients admitted to intensive care units (ICUs). Leveraging cutting-edge ...
The nasal microbiota of intensive care unit (ICU) patients effectively distinguishes sepsis from non-septic cases and outperforms analyzing the gut microbiota to predict sepsis, according to a new ...
Studies that have evaluated the use of intravenous vitamin C in adults with sepsis who were receiving vasopressor therapy in the intensive care unit (ICU) have shown mixed results with respect to the ...
In adults hospitalized with suspected sepsis, piperacillin-tazobactam was associated with a higher mortality rate and increased duration in organ dysfunction compared with cefepime, according to a ...
Morning Overview on MSN
World’s 1st targeted sepsis treatment hailed as potential lifesaving breakthrough
Grand Pharmaceutical Group Limited announced that its experimental drug STC3141 met the primary clinical endpoint in a Phase II trial conducted across sites in China, delivering a statistically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results